Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Hodgkin Lymphoma through trial conditions or approval indications mapped to it or to one of its descendant entities.
5 drugs · 58 active trials
6 drugs · 92 active trials
Outside the funnel: Phase not stated 2. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 17 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Nivolumab | Approved | Phase 3 | 28 | 8 | 3 | 54 | 2 | US | Dec 22, 2014 | Aug 2, 2012 |
| Brentuximab Vedotin | Approved | Phase 4 | 26 | 10 | 12 | 87 | 4 | US | Aug 19, 2011 | 2006-04 |
| Pembrolizumab | Approved | Phase 3 | 21 | 11 | 3 | 49 | 1 | US | Sep 4, 2014 | Nov 22, 2013 |
| Vinblastine | Approved | Phase 4 | 17 | 7 | 8 | 42 | 1 | US | Apr 29, 1987 | Jan 25, 1994 |
| Procarbazine | Approved | Phase 3 | 0 | 0 | 2 | 5 | 1 | US | Jul 22, 1969 | 2000-03 |
| Lomustine | Approved | — | 0 | 0 | 0 | 0 | 1 | US | Aug 4, 1976 | — |
| Dacarbazine | Phase 4 | Phase 4 | 23 | 10 | 10 | 48 | 0 | — | — | Jan 25, 1994 |
| Doxorubicin | Phase 4 | Phase 4 | 22 | 9 | 15 | 56 | 0 | — | — | Jan 25, 1994 |
| Bendamustine | Phase 4 | Phase 4 | 6 | 1 | 2 | 29 | 0 | — | — | 2008-06 |
| Tislelizumab | Phase 4 | Phase 4 | 5 | 3 | 3 | 10 | 0 | — | — | Apr 21, 2017 |
| Sintilimab | Phase 4 | Phase 4 | 2 | 1 | 0 | 2 | 0 | — | — | Jul 1, 2021 |
| Cyclophosphamide | Phase 3 | Phase 3 | 26 | 13 | 10 | 87 | 0 | — | — | 1988-03 |
| Fludarabine | Phase 3 | Phase 3 | 18 | 8 | 2 | 80 | 0 | — | — | 1998-01 |
| Etoposide | Phase 3 | Phase 3 | 15 | 7 | 9 | 55 | 0 | — | — | 1999-09 |
| Gemcitabine | Phase 3 | Phase 3 | 7 | 6 | 2 | 34 | 0 | — | — | 2001-09 |
| Bleomycin | Phase 3 | Phase 3 | 7 | 2 | 11 | 24 | 0 | — | — | Jan 25, 1994 |
| Vincristine | Phase 3 | Phase 3 | 7 | 2 | 6 | 20 | 0 | — | — | 2000-03 |
| Prednisone | Phase 3 | Phase 3 | 5 | 1 | 8 | 22 | 0 | — | — | 2000-03 |
| Cytarabine | Phase 3 | Phase 3 | 5 | 4 | 2 | 20 | 0 | — | — | 1999-09 |
| Dexamethasone | Phase 3 | Phase 3 | 5 | 5 | 4 | 19 | 0 | — | — | 2002-09 |
| Rituximab | Phase 3 | Phase 3 | 4 | 3 | 3 | 35 | 0 | — | — | 1999-01 |
| Filgrastim | Phase 3 | Phase 3 | 4 | 1 | 4 | 20 | 0 | — | — | 2002-09 |
| Azacitidine | Phase 3 | Phase 3 | 4 | 2 | 1 | 8 | 0 | — | — | Nov 1, 2008 |
| Carboplatin | Phase 3 | Phase 3 | 3 | 1 | 1 | 16 | 0 | — | — | 2003-08 |
| Ifosfamide | Phase 3 | Phase 3 | 3 | 1 | 3 | 16 | 0 | — | — | 2006-02 |
| Vinorelbine | Phase 3 | Phase 3 | 3 | 3 | 3 | 12 | 0 | — | — | 2001-09 |
| Sirolimus | Phase 3 | Phase 3 | 2 | 1 | 2 | 17 | 0 | — | — | 2002-07 |
| Pegfilgrastim | Phase 3 | Phase 3 | 2 | 1 | 1 | 6 | 0 | — | — | 2003-04 |
| Cisplatin | Phase 3 | Phase 3 | 2 | 2 | 2 | 5 | 0 | — | — | 2002-09 |
| Chemotherapy | Phase 3 | Phase 3 | 2 | 1 | 1 | 2 | 0 | — | — | Apr 25, 2024 |
| Methotrexate | Phase 3 | Phase 3 | 1 | 1 | 3 | 15 | 0 | — | — | 1988-03 |
| Camrelizumab | Phase 3 | Phase 3 | 1 | 0 | 1 | 6 | 0 | — | — | Jun 9, 2017 |
| Panobinostat | Phase 3 | Phase 3 | 0 | 0 | 1 | 9 | 0 | — | — | Sep 16, 2008 |
| Pentostatin | Phase 3 | Phase 3 | 0 | 0 | 1 | 4 | 0 | — | — | Dec 8, 2000 |
| Melphalan | Phase 2 | Phase 2 | 9 | 5 | 0 | 39 | 0 | — | — | 1998-01 |
| Carmustine | Phase 2 | Phase 2 | 5 | 4 | 0 | 18 | 0 | — | — | 1999-09 |
| Busulfan | Phase 2 | Phase 2 | 4 | 2 | 0 | 25 | 0 | — | — | 1988-03 |
| Thiotepa | Phase 2 | Phase 2 | 3 | 1 | 0 | 11 | 0 | — | — | Jun 29, 2006 |
| Ipilimumab | Phase 2 | Phase 2 | 2 | 0 | 0 | 9 | 0 | — | — | 2003-04 |
| Clofarabine | Phase 2 | Phase 2 | 2 | 2 | 0 | 8 | 0 | — | — | 2008-06 |
| Mosunetuzumab | Phase 2 | Phase 2 | 2 | 2 | 0 | 2 | 0 | — | — | Apr 28, 2023 |
| Polatuzumab Vedotin | Phase 2 | Phase 2 | 2 | 2 | 0 | 2 | 0 | — | — | Aug 1, 2021 |
| Lenalidomide | Phase 2 | Phase 2 | 1 | 1 | 0 | 15 | 0 | — | — | 2006-12 |
| Plerixafor | Phase 2 | Phase 2 | 1 | 1 | 0 | 10 | 0 | — | — | 2004-05 |
| Vorinostat | Phase 2 | Phase 2 | 1 | 0 | 0 | 10 | 0 | — | — | 2005-09 |
| Everolimus | Phase 2 | Phase 2 | 1 | 0 | 0 | 9 | 0 | — | — | 2009-06 |
| Ruxolitinib | Phase 2 | Phase 2 | 1 | 1 | 0 | 6 | 0 | — | — | Jul 4, 2013 |
| Ibrutinib | Phase 2 | Phase 2 | 1 | 0 | 0 | 5 | 0 | — | — | 2016-06 |
| Decitabine | Phase 2 | Phase 2 | 1 | 1 | 0 | 3 | 0 | — | — | Sep 11, 2017 |
| Oxaliplatin | Phase 2 | Phase 2 | 1 | 1 | 0 | 3 | 0 | — | — | Feb 4, 2015 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.